Search Results

Effects of Peptidic Antagonists of Grb2-SH2 on Human Breast Cancer Cells

Authors: Chen, Chiu-Heng; Chen, Meng-Kai; Jeng, Kee-Ching G.; Lung, Feng-Di T.

Source: Protein and Peptide Letters, Volume 17, Number 1, January 2010 , pp. 44-53(10)

Publisher: Bentham Science Publishers

Early Detection of Breast Cancer: New Biomarker Tests on the Horizon?

Authors: Jotwani, Aparna C.; Gralow, Julie R.

Source: Molecular Diagnosis & Therapy, Volume 13, Number 6, 1 December 2009 , pp. 349-357(9)

Publisher: Adis International

Human Epidermal Growth Factor Receptor Dimerization Analysis in Breast Cancer Diagnosis: Potential for Improving Testing Accuracy and Treatment Selection

Authors: Spears, Melanie; Bartlett, John M.S.

Source: Molecular Diagnosis & Therapy, Volume 13, Number 6, 1 December 2009 , pp. 359-365(7)

Publisher: Adis International

In vitro and in vivo biological activity of PEDF against a range of tumors

Authors: Broadhead, Matthew L; Dass, Crispin R; Choong, Peter FM

Source: Expert Opinion on Therapeutic Targets, Volume 13, Number 12, December 2009 , pp. 1429-1438(10)

Publisher: Informa Healthcare

Targeting miR-205 in breast cancer

Authors: Wu, Hailong; Mo, Yin-Yuan

Source: Expert Opinion on Therapeutic Targets, Volume 13, Number 12, December 2009 , pp. 1439-1448(10)

Publisher: Informa Healthcare

Evaluation of radioinduced damage and repair capacity in human breast cancer cells, MCF-7 and T-47D

Authors: Valgode, Flavia Gomes SilvaVal; Soares, Carlos Roberto Jorge; Bartolini, Paolo; Okazaki, Kayo

Source: International Journal of Low Radiation, Volume 6, Number 4, 18 November 2009 , pp. 343-351(9)

Publisher: Inderscience Publishers

Editorial [Hot topic: Target Therapy of Bone Metastases and Tumours (Guest Editors: M. Caraglia and D. Santini)]

Authors: Caraglia, Michele; Santini, Daniele

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 789-790(2)

Publisher: Bentham Science Publishers

Anti-Tumour Effects of Bisphosphonates - What have we Learned from In Vivo Models?

Authors: Brown, H. K.; Holen, I.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 807-823(17)

Publisher: Bentham Science Publishers

Bisphosphonates in the Prevention of Disease Recurrence: Current Results and Ongoing Trials

Author: Gnant, M.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 824-833(10)

Publisher: Bentham Science Publishers

Mapping oncology services in regional and rural Australia

Authors: Underhill, Craig; Bartel, Rebecca; Goldstein, David; Snodgrass, Helen; Begbie, Stephen; Yates, Patsy; White, Kate; Jong, Kathy; Grogan, Paul

Source: Australian Journal of Rural Health, Volume 17, Number 6, December 2009 , pp. 321-329(9)

Publisher: Blackwell Publishing

Genomics as public health? Community genetics and the challenge of personalised medicine in Cuba

Author: Gibbon, Sahra

Source: Anthropology & Medicine, Volume 16, Number 2, August 2009 , pp. 131-146(16)

Publisher: Routledge, part of the Taylor & Francis Group

Between religious philanthropy and individualised medicine: situating inherited breast cancer risk in Greece

Author: Kampriani, Eirini

Source: Anthropology & Medicine, Volume 16, Number 2, August 2009 , pp. 165-178(14)

Publisher: Routledge, part of the Taylor & Francis Group

Luteinizing hormone-releasing hormone (LHRH) agonists in the treatment of breast cancer

Author: Hackshaw, Allan

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 16, November 2009 , pp. 2633-2639(7)

Publisher: Informa Healthcare

Evaluation of HER2 in breast cancer: reality and expectations

Authors: Milanezi, Fernanda; Leitão, Dina; Ricardo, Sara; Augusto, Isabel; Schmitt, Fernando

Source: Expert Opinion on Medical Diagnostics, Volume 3, Number 6, November 2009 , pp. 607-620(14)

Publisher: Informa Healthcare

Molecular mechanisms underlying proliferation and apoptosis in breast cancer MCF-7 cells induced by pentabrominated diphenyl ethers

Authors: Yu, Lin; Zhan, Ping

Source: Toxicological and Environmental Chemistry, Volume 91, Number 4, June 2009 , pp. 665-670(6)

Publisher: Taylor and Francis Ltd

Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: The TEAM Trial Experience

Authors: Faratian, Dana; Kay, Charlene; Robson, Tammy; Campbell, Fiona M; Grant, Margaret; Rea, Dan; Bartlett, John M S

Source: Histopathology, Volume 55, Number 5, November 2009 , pp. 587-593(7)

Publisher: Blackwell Publishing

Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles

Authors: Lopes, Nair; Sousa, Bárbara; Vieira, Daniella; Milanezi, Fernanda; Schmitt, Fernando

Source: Histopathology, Volume 55, Number 5, November 2009 , pp. 594-599(6)

Publisher: Blackwell Publishing

Biological role of NHERF1 protein expression in breast cancer

Authors: Mangia, Anita; Chiriatti, Annalisa; Bellizzi, Antonia; Malfettone, Andrea; Stea, Baldassarre; Zito, Francesso Alfredo; Reshkin, Stephen Joel; Simone, Giovanni; Paradiso, Angelo

Source: Histopathology, Volume 55, Number 5, November 2009 , pp. 600-608(9)

Publisher: Blackwell Publishing

The Yale University Experience of Early-Stage Invasive Lobular Carcinoma (ILC) and Invasive Ductal Carcinoma (IDC) Treated with Breast Conservation Treatment (BCT): Analysis of Clinical-Pathologic Features, Long-Term Outcomes, and Molecular Expression of COX-2, Bcl-2, and p53 as a Function of Histology

Authors: Moran, Meena S.; Yang, Qifeng; Haffty, Bruce G.

Source: The Breast Journal, Volume 15, Number 6, November/December 2009 , pp. 571-578(8)

Publisher: Blackwell Publishing

Quantification of Radio-tracer Uptake in Axillary Lymph Nodes using Breast Specific Gamma Imaging (BSGI): Benign Radio-tracer Extravasation versus Uptake Secondary to Breast Cancer

Authors: Werner, John; Rapelyea, Jocelyn A.; Yost, Kristen G.; Brem, Rachel F.

Source: The Breast Journal, Volume 15, Number 6, November/December 2009 , pp. 579-582(4)

Publisher: Blackwell Publishing